Tweet
J Ethnopharmacol. 2018 Feb 19. pii: S0378-8741(17)33670-X. doi: 10.1016/j.jep.2018.02.016. [Epub ahead of print]
Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection.
Zhu H1, Lu X2, Ling L3, Li H2, Ou Y2, Shi X1, Lu Y3, Zhang Y4, Chen D5.
Author information
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE:
Hottuynia cordata is an important traditional Chinese medicine for the treatment of respiratory diseases including bacterial and viral infections. Polysaccharides isolated from Houttuynia cordata (HCP), as its main ingredients, have been demonstrated to ameliorate the LPS-induced acute lung injury in mice. The study aimed to determine the protective effects of HCP on multiple organ injury in influenza A virus (IAV) H1N1 infected mice and its primary mechanisms in anti-inflammation and immune regulation.
MATERIALS AND METHODS:
Mice were inoculated with IAV H1N1 and then treated with 20 or 40 mg/kg/d of HCP for survival test and acute lung-gut injury test.
RESULTS:
The treatment with HCP resulted in an increase in the survival rate of H1N1 infected mice and the protection from lung and intestine injury, accompanied with the reduced virus replication. HCP markedly decreased the concentration of pulmonary proinflammatory cytokines/chemokines and the number of intestinal goblet cells, and strengthened the intestinal physical and immune barrier, according to the increase of sIgA and tight junction protein (ZO-1) in intestine. At the same time, the inhibition of inflammation in lung and gut was related to the suppressing of the expression of TLR4 and p-NFκB p65 in lung.
CONCLUSIONS:
These results indicated that HCP ameliorated lung and intestine injury induced by IAV attack. The mechanisms were associated with inhibition of inflammation, protection of intestinal barrier and regulation of mucosal immunity, which may be related to the regulation of gut-lung axis. As an alternative medicine, HCP may have clinical potential to treat IAV infection in human beings.
Copyright ? 2018. Published by Elsevier B.V.
KEYWORDS:
Gut-lung axis; HCP; Influenza A virus; Intestine injury; Lung injury
PMID: 29471085 DOI: 10.1016/j.jep.2018.02.016
Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection.
Zhu H1, Lu X2, Ling L3, Li H2, Ou Y2, Shi X1, Lu Y3, Zhang Y4, Chen D5.
Author information
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE:
Hottuynia cordata is an important traditional Chinese medicine for the treatment of respiratory diseases including bacterial and viral infections. Polysaccharides isolated from Houttuynia cordata (HCP), as its main ingredients, have been demonstrated to ameliorate the LPS-induced acute lung injury in mice. The study aimed to determine the protective effects of HCP on multiple organ injury in influenza A virus (IAV) H1N1 infected mice and its primary mechanisms in anti-inflammation and immune regulation.
MATERIALS AND METHODS:
Mice were inoculated with IAV H1N1 and then treated with 20 or 40 mg/kg/d of HCP for survival test and acute lung-gut injury test.
RESULTS:
The treatment with HCP resulted in an increase in the survival rate of H1N1 infected mice and the protection from lung and intestine injury, accompanied with the reduced virus replication. HCP markedly decreased the concentration of pulmonary proinflammatory cytokines/chemokines and the number of intestinal goblet cells, and strengthened the intestinal physical and immune barrier, according to the increase of sIgA and tight junction protein (ZO-1) in intestine. At the same time, the inhibition of inflammation in lung and gut was related to the suppressing of the expression of TLR4 and p-NFκB p65 in lung.
CONCLUSIONS:
These results indicated that HCP ameliorated lung and intestine injury induced by IAV attack. The mechanisms were associated with inhibition of inflammation, protection of intestinal barrier and regulation of mucosal immunity, which may be related to the regulation of gut-lung axis. As an alternative medicine, HCP may have clinical potential to treat IAV infection in human beings.
Copyright ? 2018. Published by Elsevier B.V.
KEYWORDS:
Gut-lung axis; HCP; Influenza A virus; Intestine injury; Lung injury
PMID: 29471085 DOI: 10.1016/j.jep.2018.02.016